Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia

计划入组 26 人 · 首次发布于 2026 年 8 月 17 日

Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

计划入组 32 人 · 首次发布于 2026 年 6 月 16 日

CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.

计划入组 20 人 · 首次发布于 2026 年 4 月 20 日

(R,R')-penehyclidine fumarate

(R,R)-2,3-Butanediol

C₄H₁₀O₂

Rick Hansen Institute

Canada

R&R, Inc.

United States

Anabio R&D

Vietnam

AstraZeneca Names Rick Suarez US President to Lead $50 Billion Investment Strategy

P-BCMA-ALLO1 Demonstrates Promising Efficacy and Safety in Relapsed/Refractory Multiple Myeloma

Navtemadlin Shows Promise in JAK Inhibitor-Refractory Myelofibrosis